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http://www.biomedcentral.com/1756-0500/7/738RESEARCH ARTICLE Open AccessAcute elevation of intra-abdominal pressure
contributes to extravascular shift of fluid and
proteins in an experimental porcine model
Bjørg Elvevoll1, Paul Husby1, Kjell Øvrebø2 and Oddbjørn Haugen1*Abstract
Background: Intra-abdominal hypertension and abdominal compartment syndrome contribute significantly to
increased morbidity and mortality in critically ill patients. This study describes pathophysiologic effects of the
acutely elevated intra-abdominal pressure on microvascular fluid exchange and microcirculation. The resulting
changes could contribute to development of organ dysfunction or failure.
Methods: 16 pigs were randomly allocated to a control-group (C-group) or an interventional group (P-group). After
60 min of stabilization, intra-abdominal pressure of the P-group animals was elevated to 15 mmHg by Helium
insufflation and after 120 min to a level of 30 mmHg for two more hours. The C-group animals were observed without
insufflation of gas. Laboratory and hemodynamic parameters, plasma volume, plasma colloid osmotic pressure, total
tissue water content, tissue perfusion, markers of inflammation and cerebral energy metabolism were measured and
net fluid balance and fluid extravasation rates calculated. Analysis of variance for repeated measurements with
post-tests were used to evaluate the results with respect to differences within or between the groups.
Results: In the C-group hematocrit, net fluid balance, plasma volume and the fluid extravasation rate remained essentially
unchanged throughout the study as opposed to the increase in hematocrit (P < 0.001), fluid extravasation rate (P < 0.05)
and decrease in plasma volume (P < 0.001) of the P-group. Hemodynamic parameters remained stable or were slightly
elevated in the C-group while the P-group demonstrated an increase in femoral venous pressure (P < 0.001), right atrial
pressure (P < 0.001), pulmonary capillary wedge pressure (P < 0.01) and mean pulmonary arterial pressure (P < 0.001). The
protein mass decreased in both study groups but was significantly lower in the P-group as compared with the C-group,
after 240 min of intervention. The increased intra-abdominal pressure was associated with elevated intracranial pressure
and reduced tissue perfusion of the pancreas and the gastric- and intestinal mucosa.
Conclusion: Elevation of intra-abdominal pressure has an immediate impact on microvascular fluid extravasation leading
to plasma volume contraction, reduced cardiac output and deranged perfusion of abdominal organs.
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Intra-abdominal hypertension (IAH) and abdominal com-
partment syndrome (ACS) are known to affect morbidity
and mortality in the critically ill patient [1,2]. Depending
on the patient populations, the incidence of IAH has been
reported in the range of 32-50% [2-4].* Correspondence: oddb@helse-bergen.no
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groups of patients, with an incidence found to be around
4% in a general medical-surgical population [2,5].
The underlying pathophysiological mechanisms are not
fully understood, but are frequently related to an increase in
the intra-abdominal volume resulting in a shift to the
steeper part of the abdominal pressure-volume curve. A
reduction in abdominal wall compliance could lead to the
same result. Factors contributing to an increase in intra-
abdominal volume could be regional such as intra-
abdominal hemorrhage, ascites formation or intestinall Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Elvevoll et al. BMC Research Notes 2014, 7:738 Page 2 of 10
http://www.biomedcentral.com/1756-0500/7/738dilatation [6,7]. The condition may also follow massive fluid
resuscitation, as in sepsis or burn injuries, leading to
increased extravasation of fluid from the vascular to the
interstitial space and edema formation [8].
The transcapillary fluid shift is basically determined by
the forces of the classic Starling equation containing the
capillary filtration coefficient, the reflection coefficient for
plasma proteins, and the balance between the intra- and
extra-capillary hydrostatic and colloid osmotic pressures
[9]. The capillary hydrostatic pressure (Pc) is influenced
partly by the pre- and post-capillary resistance, but more
strongly by the central venous pressure. Previous studies
on intra-abdominal hypertension have demonstrated that
this condition may be accompanied by elevated central
venous pressure [10].
In the present study we assessed the early changes in
fluid- and protein shifts following acute elevation of intra-
abdominal pressure (IAP) to a level of 15 and thereafter
30 mmHg, corresponding to grade 2 and grade 4 of IAH,
respectively [7]. Based on previous observations on central
venous pressure during IAH, we hypothesized that acute
elevation of intra-abdominal pressure, per se, would lead
to an increase in fluid filtration from the capillaries to the
interstitial space.
Methods
Animal handling and anesthesia
16 immature domestic pigs (Norwegian landrace-Yorkshire
hybrid) were studied. The animal handling was following
recommendations given by the Norwegian State Commis-
sion for Laboratory animals and in accordance with inter-
nationally recognized guidelines. The study protocol was
approved by the Institutional Veterinarian Authority
(12.03.2012 # 20124218) prior to start of the study. All ani-
mals were acclimatized in the facilities for at least five days
before the experiments. Water was provided at all times,
but food was withdrawn 8-12 h prior to induction of
anesthesia.
The animals were pre-medicated with Ketamine 500 mg,
diazepam 10 mg and atropine 1 mg i.m. General anesthesia
was induced via a face mask with Isoflurane in oxygen,
supplemented by Thiopentone 5 mg/kg i.v. after establish-
ing i.v. access in an ear vein. They were then oro-tracheally
intubated (Mallinckrodt, blueline oral tube, I.D 6.0, Covi-
dien plc, Dublin, Ireland). General anesthesia was main-
tained by volume-controlled ventilation with Isoflurane
0.5-2.0% delivered in 40-60% oxygen in air via a ventilator
(Julian anesthesia work station, Dräger, Lübeck, Germany)
and continuous i.v. infusion of Midazolam (0.5 mg/kg/h)
and Fentanyl (7.5 μg/kg/h). The anesthesia protocol is
previously described [11].
All animals were given continuous i.v. infusion of
acetated Ringer’s solution (10 ml/kg/h) from induction of
anesthesia. Blood samples and bleeding were substitutedfor by acetated Ringer’s solution in volumes three times the
volume of blood lost from circulation. The amount of
blood loss was measured by weighing the surgical sponges.
Hypothermia was prevented by heating blankets. At the
end of the experiments, the animals were killed by an i.v.
injection of 20 ml saturated KCl-solution.
Surgical procedures and hemodynamic monitoring
A cranial burr hole with a diameter of 0.5 cm was made
in the frontal bone of the pig skull while in the prone
position. Dura mater was incised and a pressure trans-
ducer (Codman MicroSensor ICP Transducer, Johnson
& Johnson Proffesional Inc., Raynham, MA, USA) intro-
duced 20 mm into the brain parenchyma and connected
to a Codman Express™ monitor. A microdialysis catheter
(CMA 70, 20 mm, Cutoff 20 000 Dalton, CMA microdi-
alysis AB, Stockholm, Sweden) was inserted through the
burr hole and placed with the tip 25 mm into the brain
parenchyma.
Thereafter, in the supine position, the femoral artery
and vein were surgically exposed and catheters intro-
duced into the respective vessels (Secalone T™, 18G, BD
Medical, Singapore). Mean arterial pressure (MAP) and
femoral venous pressure (CVPFV) were continuously
monitored through fluid-filled lines connected to trans-
ducers (TranspacTM П, Abbot Critical Care Systems,
Sligo, Ireland) linked to a monitor (HP-78353A, Hewlett
Packard, Palo Alto, CA, USA). Heart rate was monitored
through surface ECG-electrodes.
The right external jugular vein was surgically exposed
and a Swan-Ganz catheter introduced and positioned in
the pulmonary artery for recording of mean pulmonary
artery pressure (MPAP), pulmonary capillary wedge
pressure (PCWP), right atrial pressure (CVPRA) and
continuous cardiac output (CCO) (7,5 F Swan Ganz
Thermodilution catheter, Edwards Lifesciences, Irvine,
CA, USA). The pressure values were displayed on the
same monitor as were femoral arterial- and venous
pressure while CCO was processed and displayed by
a Vigilance II unit (Edwards Lifesciences, Irvine, CA,
USA). The left carotid artery was surgically exposed and
a single lumen polyethylene catheter placed with the tip
in the left ventricle, for injection of fluorescent micro-
spheres. The position was verified by pressure curve
assessment.
Finally a mini-laparotomy was performed through an in-
cision to the left of the abdominal midline above the pubic
bone. The urinary bladder was punctured and a Foley cath-
eter introduced for monitoring of urinary output. The
abdominal wall was punctured and a triple lumen central
venous catheter (12 F 3-lumen catheter, 16 cm, Arrow-
Howes™ Large-Bore Multi-lumen CVC-Set, Arrow Inter-
national, Inc. Reading, PA, USA) was placed in the
abdominal cavity, with the tip in the left upper quadrant.
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monitoring of IAP and to a 10 liter cylinder of Helium
(≥99,996% Helium, Aga AS, Oslo, Norway) for insufflation
of gas. To obtain an airtight closure of the abdominal wall,
a thin plastic film was placed over the bowels before the
wound was closed in layers by running stiches.
Study protocol
The animals were randomized to either the intervention
group (P-group, n = 8) or the control group (C-group, n
= 8). Following surgical preparation, all animals were
stabilized for 60 minutes before intervention. The intra-
abdominal pressure of the P-group was then elevated to
15 mmHg through insufflation of Helium into the ab-
dominal cavity. After 120 minutes the pressure was fur-
ther elevated to 30 mmHg and maintained at this level
for 120 minutes. When necessary, additional helium was
insufflated to maintain the target level of pressure. The
C-group animals were observed for the same time
period without interventions.
Plasma-volume, net fluid balance and fluid extravasation
rate
After 30 minutes of stabilization, red blood cell volume
(VRBC) was determined using carbon monoxide as label.
The method is previously presented in detail [12]. Dur-
ing the rest of the experiment new values for VRBC were
calculated every 30 minutes based on baseline VRBC,
repeated hematocrit measurements and recorded loss of
blood. The corresponding values for plasma volume
(PV) were also calculated. Urine output was recorded
every 30 minutes, and net fluid balance (NFB) was calcu-
lated as the total amount of fluid added minus the
recorded loss of fluid during every 30 minutes. Fluid
extravasation (FE) was defined as NFB minus the change
in PV (ΔPV) over the same time interval:
FE ml=kgð Þ ¼ NFB ml kgð Þ ‐ΔPV ml kgð Þ
The resulting fluid extravasation rate (FER) was pre-
sented as ml/kg/min.
Blood chemistry
Blood samples were drawn from the arterial line for
determination of hemoglobin concentration (Hb), hema-
tocrit (Hct), serum-albumin, serum-total protein, serum-
electrolytes, serum-osmolality and acid-base parameters.
Hct was determined using standard hematocrit-tubes cen-
trifuged at 12000 rpm for 10 min. Serum-albumin, serum-
total protein concentrations and serum-electrolytes were
analyzed in an automatic analyzer (Clinical analyzer 7600,
Modular P, Hitatchi High-Tecnologies Corporation, Tokyo,
Japan). Albumin- and protein masses were calculated by
multiplying serum levels with simultaneous plasma volume.Serum-osmolality was analyzed by freezing point determin-
ation. Blood glucose was analyzed by test strips (MediSense
precision Xtra glucose analyzer, MediSense UK, Oxon UK).
Microdialysis
The microdialysis catheter was perfused with CNS perfu-
sion fluid (CMA) by a microinfusion pump (CMA 107)
with a flow rate of 0.3 μl/min. Samples of microdialysate
were collected in microvials and analyzed by a CMA 600
Microanalyser every 30 minutes with respect to glucose,
lactate, pyruvate and glycerol. The method is previously
validated [13].
Inflammatory mediators
Serum levels of tumor necrosis factor alpha (TNF-α)
and interleukine-6 ( IL-6) were measured by a quantitative
sandwich enzyme immunoassay technique (Quantikine,
Porcine Immunoassay by R&D Systems, Minneapolis,
MN, USA) according to the manufacturer protocol. The
reported mean minimum detectable dose of IL-6 and
TNF-α were 2.03 pg/ml and 3.7 pg/ml, respectively.
The microsphere method
Regional blood flow was measured by colored microspheres
in different tissues and organs. The method is based upon
the notion that 15 μm colored spheres after homogenous
mixing in arterial blood become trapped in the capillaries
to an extent proportional to the regional blood flow [14].
Microspheres were infused into the left ventricle through
the catheter in the left carotid artery followed by constant
rate retraction of blood from the femoral artery for refer-
ence. The number of spheres in various tissues and refer-
ence blood was calculated by digestion of samples in 4
Molar KOH and subsequent filtration through a 10 μm
Teflon filter. The dye was released from the spheres with
dimethylformamid and the content of each dye was then
measured in a spectrophotometer.
Total tissue water (TTW)
Immediately after killing the animal, tissue samples, in
doubles, were taken from left quadriceps muscle, right-
and left ventricular myocardium, lung, liver, left- and right
kidney, the mucosal-and muscular layer of the ventricle,
pancreas, the mucosal and muscular layer of the ileum,
brain and abdominal skin. The tissue samples were placed
in pre-weighed vials, reweighed and placed in a drying
chamber at 70°C. The vials were weighed repeatedly until
stable weight, and the weight reduction was considered to
represent the water content of the tissue. TTW was re-
corded as g/g dry weight.
Statistical analysis
All data were analyzed with IBM SPSS 21 for Windows
(SPSS Inc., Chicago, IL, USA). Graphic presentations were
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Software, Inc, La Jolla, CA, USA). Analysis of variance for
repeated measurements, with one within group factor
(time) and one between group factor (intra-abdominal pres-
sure) was used. On finding a significant between-group
difference or a significant interaction between the study
groups, independent t-tests or Mann Whitney U test were
performed to compare the groups at baseline and after 60,
120, 180 and 240 minutes of intervention. If a significant
within-group difference was found, paired t-tests were
performed to compare the baseline values with the values
obtained after 60, 120, 180 and 240 minutes of intervention.
For hematocrit, plasma volume, net fluid balance and
fluid extravasation rate the statistical analysis were based
upon average values during the 60 minutes of stabilization
(Baseline), the first 120 minutes, and the last 120 minutes
of the intervention.
Results
The animals of the C-group and P-group were comparable
with respect to age: 103.9 (22.3) and 93.1 (10.3) days,
weight: 41.94 (2.65) and 41.92 (3.1) kg and surface area: 1.1
(0.04) and 1.1 (0.05) m2, respectively. The gender of the C-
group and P-group animals were 7/1 and 3/5 (male/female)
in the respective groups.
The Baseline values in the tables and figures corres-
pond to measured or calculated values after 1 hour of
stabilization. Mean arterial pressure (MAP), mean pul-
monary artery pressure (MPAP), pulmonary capillary
wedge pressure (PCWP), central venous pressure ob-
tained from the right atrium (CVPRA) and the femoral
vein (CVPFV) and intra-abdominal pressure (IAP) are
displayed in Figure 1. MAP remained essentially stable
with no between-group differences during the study. In
the P-group MPAP increased from 20.0 (3.7) mmHg at
baseline to 30.4 (4.7) mmHg after 240 min (P < 0.001) in
contrast to the modest changes in the C-group with
18.5 (4.5) mmHg at baseline and 21.6 (4.4) mmHg after
240 min (P < 0.001). Between-group differences were
present from 60 minutes after intervention (P < 0.05).
Also, PCWP showed an increase in the P-group from
11.0 (3.0) mmHg at baseline to 16.0 (3.6) mmHg at the
end of the experiment. In the C-group PCWP remained
stable. CVPRA increased slightly in the C-group with 8.0
(2.0) mmHg at baseline and 8.9 (2.4) mmHg at 240 min
(P < 0.05) in contrast to the P-group where correspond-
ing values increased from 7.5 (2.9) mmHg to 13.0 (2.6)
mmHg (P < 0.001 within-group and P < 0.05 between-
group differences at 240 min). A similar, but more obvi-
ous pattern was seen in CVPFV, where the values of the
C-group were 8.8 (1.9) mmHg at baseline and 10.2 (2.1)
mmHg after 240 min while CVPFV of the P-group in-
creased from 9.6 (1.3) mmHg at baseline to 17.3 (2.3)
mmHg after 120 min (P < 0.001) and 28.5 (5.7) mmHgafter 240 min (P < 0.001). The values differed signifi-
cantly between the groups from 60 minutes after inter-
vention (P < 0.001). They closely followed IAP which in
the C-group was 4.4 (2.4) mmHg at baseline and 5.4
(3.4) mmHg at the end of the experiment, and in the P-
group was 5.5 (2.4) mmHg at baseline and finally 30.0
(1.9) mmHg.
The results of cardiac output (CO), systemic vascular
resistance (SVR), pulmonary vascular resistance (PVR),
intracerebral pressure (ICP) and cerebral perfusion pres-
sure (CPP) are displayed in Table 1. CO, SVR and PVR
remained essentially stable in the C-group throughout
the experiment. In the P-group CO decreased signifi-
cantly at 180 min (P < 0.05) and 240 min (P < 0.05) as
compared with baseline values and after 180 min CO
was significantly lower than the corresponding value of
the C-group (P < 0.05). As opposed to the C-group, SVR
increased in the P-group and differed significantly from
the C-group after 180 min of intervention (P < 0.001
within-group-, P < 0.05 between-group differences). PVR
of the P-group was significantly elevated after 240 min
when compared to baseline (P < 0.05) and a tendency to
increasing values of PVR was also seen in the C-group.
ICP increased significantly in the P-group after 120 min
(P < 0.001). No significant increase in ICP of the C-
group was found although a trend was seen. With re-
spect to CPP, a slight decreasing trend was present in
both groups during the experiments with no between-
group differences.
Figure 2 displays the average levels of hematocrit, net fluid
balance (NFB), plasma volume (PV) and fluid extravasation
rate (FER) at baseline, during the first 120 min (0-120 min)
and the last 120 min (120 to 240 min) of the experiments in
the respective study groups. In the P-group, hematocrit
increased from 27.7 (1.6)% at baseline to 32.4 (1.9)% at 120
to 240 min (P < 0.001) while the values of the C-group
remained stable at 26.1 (1.9) and 25.8 (2.2)%. PV of the
P-group was reduced from 60.9 (7.5) ml/kg at baseline to
47.2 (6.3) ml/kg (P < 0.001) at 120 to 240 min. The
corresponding values of the C-group were 65.1 (6.2) ml/kg
and 64.3 (5.9) ml/kg. A trend to increasing NFB was seen in
the P-group with 0.16 (0.03) ml/kg/min at baseline and
0.19 (0.005) ml/kg/min during 120 to 240 min while
the corresponding values of the C-group were 0.18
(0.005) ml/kg/min and 0,18 (0.01) ml/kg/min. NFB of
the study groups differed significantly at 120 to 240 min
(P < 0.05). FER increased from 0.19 (0.05) ml/kg/min at
baseline to 0.27 (0.03) ml/kg/min at 120 to 240 min in the
P-group (P < 0.01) while the C-group values remained stable
with 0.18 (0.02) ml/kg/min and 0.17 (0.03) ml/kg/min.
Laboratory parameters are presented in Table 2. The al-
bumin and protein masses decreased in both study groups
throughout the experiments although the reduction was
more pronounced in the P-group. At 240 min the level
Figure 1 The figure shows A: Mean arterial pressure (MAP), B: Mean pulmonary arterial pressure (MPAP), C: Pulmonary capillary
wedge pressure (PCWP), D: Right atrium central venous pressure (CVPRA), E: Femoral vein central venous pressure (CVPFV) and F:
Intra-abdominal pressure (IAP) in the ●: Intervention group (P-group) and the ○: Control-group (C-group) **: P < 0.01 ***: P < 0.001
within group difference compared with baseline values; # : P < 0.05 ##:P < 0.01 ###: P < 0.001 between group difference, same time.
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when compared with the C-group (P < 0.05). PaCO2 was
significantly higher and BE lower in the P-group as com-
pared with the C-group at 240 min resulting in a lower
pH, but the numeric difference was modest. Interleukin-6increased slightly in both study groups (P < 0.01) as did
TNF-α in the P-group (P < 0.05).
Table 3 displays the blood glucose and markers of
cerebral metabolism in fluid collected by cerebral micro-
dialysis. Both study groups showed a reduction in blood
Table 1 Hemodynamic parameters
Parameter Group Baseline 60 min 120 min 180 min 240 min
CO C-group 5.1 (0.6) 5.3 (0.9) 5.2 (1.1) 5.1 (0.8)# 4.8 (0.9)
(l/min) P-group 5.4 (0.6) 5.2 (0.8) 5.1 (0.8) 3.8 (0.9)* 4.3 (0.6)*
SVR C-group 905.9 (155) 876.8 (145,2) 896.4 (250,8) 835.2 (153.9)# 871.7 (134.4)
(dynes/sec/cm-5) P-group 960.7 (131) 970.7 (180,5) 946.9 (120,4) 1299.2 (201.3)*** 1128.8 (183.3)
PVR C-group 128.6 (41.6) 123.9 (21.8) 137.8 (25.1) 144.5 (28.3) 211.9 (100.1)
(dynes/sec/cm-5) P-group 134.7 (23) 138.2 (18) 151.6 (27.1) 249.4 (112.9) 250.6 (82)*
ICP C-group 16.3 (2.9) 17.3 (3.1) 19.9 (4.9) 20.8 (6.0) 20.6 (5.8)
(mmHg) P-group 16.9 (5.9) 21.6 (4.9) 24.0 (7.3)*** 26.7 (4.0)*** 26.9 (5.9)***
CPP C-group 54.0 (11.0) 52.8 (11.7) 40.1 (20.2) 45.1 (15.2) 44.4 (13.7)
(mmHg) P-group 52.7 (5.0) 50.9 (5.0) 48.4 (6.8) 50.6 (7.6) 47.0 (7.4)
Values are presented as mean with SD in parentheses. Control group: C-group; Intervention group: P-group; CO: cardiac output; SVR: systemic vascular resistance; PVR:
pulmonary vascular resistance; ICP: intracranial pressure; CPP: cerebral perfusion pressure.
*: P < 0.05 ***: P < 0.001; within group difference compared with baseline values;
#: P < 0.05; between group differences, same time.
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The other metabolic markers remained stable with no
significant changes.
Total water content in various tissue and organs are
shown in Table 4. The kidneys and the lungs of
the P-group animals contained significant less water
than those of the C-group. Otherwise no significantFigure 2 The figure displays A: Hematocrit, B: Net fluid balance, C: Pl
group (P-group) (black columns) and the control group (C-group) (wh
compared with baseline values; #: P < 0.05 ##: P < 0.01 ###: P < 0.001differences in water content between the study groups
were found.
Table 5 demonstrates the microcirculatory changes as
measured with colored microspheres. The perfusion of
the ileal and ventricular mucosa was reduced in the P-
group by the end of the experiment. Pancreas perfusion
was reduced in the P-group and elevated in the C-group.asma volume and D: Fluid extravasation rate in the Intervention
ite columns); **: P < 0.01 ***: P < 0.001 within group difference
between group difference, same time.
Table 2 Laboratory parameters
Parameter Group Baseline 60 min 120 min 180 min 240 min
Natrium C-group 139.4 (1.4) 139.1 (1.5) 139.1 (2.4) 139.1 (2.4) 138.2 (1.4)**
(mmol/l) P-group 139.0 (1.5) 138.9 (1.8) 138.4 (2.3) 138.0 (3.2) 138.0 (2.1)
Kalium C-group 4.2 (0.2) 4.4 (0.3)* 4.6 (0.3)** 4.9 (0.3)*** 5.3 (0.5)***
(mmol/l) P-group 4.3 (0.5) 4.5 (0.5)* 5.0 (0.7)** 5.9 (1.2)* 6.1 (0.9)***
Chloride C-group 99.1 (1.4) 98.6 (0.9) 98.6 (0.9) 99.4 (1.1) 98.6 (1.1)
(mmol/l) P-group 99.2 (1.3) 98.5 (1.2) 98.6 (2.3) 98.1 (2.0) 98.9 (1.7)
Osmolalitet C-group 285.8 (2.4) 288.4 (6,6) 283.8 (1.8) 282.8 (3.6) 284.5 (4.9)
(mosm/l) P-group 282.4 (4.6) 281.9 (2.7) 283.1 (3.6) 284.3 (3.2) 285.9 (4.7)
s-Protein C-group 47.0 (2.1) 46.4 (2.1) 44.5 (2.1)** 43.4 (1.8)*** 43.3 (1.2)**
(g/l) P-group 46.9 (3.1) 49.3 (3.4)* 47.9 (3.2) 47.9 (4.4) 47.8 (3.6)#
s-Albumin C-group 31.1 (4.3) 30.9 (4.0) 29.5 (4.3)** 29.8 (3.7) 28.9 (3.4)*
(g/l) P-group 31.4 (2.9) 32.6 (3.0) 31.9 (2.4) 32.3 (2.4) 32.3 (2.7)
Albuminmass C-group 2,02 (0.42) 1.98 (0.39) 1.89 (0.37)* 1.93 (0.37) 1.87 (0.41)**
(g/kg) P-group 1.86 (0.21) 1.76 (0.22)** 1,71 (0.21)*** 1.52 (0.21)*** 1.45 (0.19)***
Proteinmass C-group 3.03 (0.3) 2.97 (0.31) 2.84 (0.28)* 2.8 (0.25)* 2.78 (0.32)*
(g/kg) P-group 2.79 (0.41) 2.67 (0.43)** 2.59 (0.41)*** 2.28 (0.43)*** 2.16 (0.33)#***
Hemoglobin C-group 8.0 (0.6) 7.8 (0.6)## 7.9 (0.8)# 7.9 (0.9)### 7.7 (0.8) ###
(g/100 ml) P-group 8.6 (0.6) 9.1 (0.6)** 9.2 (0.8)** 9.9 (0.6)*** 10.1 (0.7)***
pH C-group 7.50 (0.04) 7.50 (0.03) 7.51 (0.04) 7.50 (0.03) 7.51 (0.02)##
P-group 7.52 (0.05) 7.50 (0.04) 7.49 (0.04) 7.45 (0.06) 7.43 (0.05)*
BE C-group 7.74 (1.5) 8.08 (1.5) 8.31 (1.2) 8.49 (1.1)## 7.81 (1.1)##
(mmol/l) P-group 7.65 (1.1) 7.36 (1.1) 6.85 (1.0) 5.68 (1.5) 5.29 (1.2)*
PaCO2 C-group 5.3 (0.5) 5.5 (0.4) 5.3 (0.5) 5.5 (0.5) 5.2 (0.5)#
(kPa) P-group 5.1 (0.7) 5.3 (0.6) 5.4 (0.4) 5.8 (0.9) 6.2 (0.7)
HCO3
- C-group 31.5 (1.4) 31.8 (1.4) 32.1 (1.1) 32.2 (1.0)# 31.6 (0.9)##
(mmol/l) P-group 31.4 (0.9) 31.2 (1.1) 30.7 (1.0) 29.7 (1.7) 29.1 1.3)*
PaO2 C-group 34.4 (11.9) 28.1 (5.4) 26.9 (4.0) 26.0 (4.8) 26.2 (5.6)
(kPa) P-group 25.8 (4.9) 24.7 (4.0) 24.1 (5.5) 24.8 (4.5) 22.7 (5.3)
TNF-α C-group 72.0 (28.9) 79.5 (27.3) 83.0 (27.0) 77.1 (24.1) 80.7 (29.0)
(pg/ml) P-group 56.8 (21.1) 63.2(19.4) 64.7 (22.1) 87.8 (29.6)** 91.4 (38.4)*
Interleukin-6 C-group 3.6 (4.7) 9.0 (3.4)** 17.6 (3.4)*** 23.9 (8.0)*** 30.2 (14.5)**
(pg/ml) P-group 10.5 (7.8) 16.5 (11.8)** 30.9 (13.1)*** 52.8 (26.2)*** 83.0 (64.4)
Results as means with SD in parentheses; Control group: C-group; Intervention group: P-group; *:P<0.05 **:P<0.01 ***:P<0.001; within group differences compared with
baseline values; #:P<0.05 ##:P<0.01 ###:P<0.001; between group differences, same time.
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the groups (P < 0.001).
The kidney perfusion was higher in the P-group than
the C-group at baseline and decreased in both groups
during the experiments. The percentage reduction was
19.8 (12.0) and 18.0 (7.7) in the left and right kidney of
the C-group, and 50.1 (6.1) and 52.4 (5.0) in the left and
right kidney of the P-group (P < 0.001, between group-
difference). Skin perfusion increased in the C-group, and
the levels were higher than in the P-group at the end of
the experiments (P < 0.05). Cerebral perfusion wasslightly increased in the P-group during the intervention
(P < 0.05) with no between-group difference.
Discussion
The clinical condition of acute intra-abdominal hyper-
tension is frequently associated with elevated capillary
permeability and abundant edema formation following
local or systemic inflammatory processes [4,15]. The
present study demonstrate the reverse causal relation-
ship: An acute elevation of intra-abdominal pressure
contributes per se to a shift of fluid and proteins from
Table 3 Markers of cerebral metabolism
Parameter Group Baseline 60 min 120 min 180 min 240 min
B-glucose C-group 6.6 (1.1) 6.4 (0.8) 6.2 (10.9) 5.6 (0.9) 4.9 (1.2)**
(mmol/l) P-group 6.2 (2.2) 6.0 (2.0) 5.6 (1.7) 4.1 (2.1) 3.2 (1.3)**
C-glucose C-group 2.5 (1.3) 2.6 (0.8) 2.1 (0.6) 1.7 (0.7) 1.4 (0.8)
(mmol/l) P-group 3.2 (1.7) 3.1 (1.0) 2.7 (0.9) 2.1 (1.4) 1.7 (1.3)
C-Lactate C-group 3.5 (0.9) 3.9 (1.0) 4.8 (1.4) 5.4 (1.7) 5.4 (1.7)
(mmol/l) P-group 4.1 (1.6) 4.9 (1.7) 5.5 (2.3) 5.4 (2.7) 5.2 (2.6)
C-Pyruvate C-Group 212 (137) 243 (103) 283 (110) 294 (117) 289 (91)
(μmol/l) P-group 264 (135) 326 (127) 320 (116) 340 (168) 296 (140)
L/P- ratio C-group 2.7 (3.4) 1.6 (1.1) 1.7 (1.3) 1.8 (1.5) 1.8 (1.5)
P-group 1.1 (0.9) 1.1 (0.8) 1.2 (0.8) 1.1 (0.7) 1.2 (0.8)
C-glycerol C-group 44.2 (29.1) 44.3 (17.7) 41.0 (12.2) 40.3(14.0) 38.5 (13.3)
(μmol/l) P-group 45.8 (43.2) 39.5 (38.7) 45.5 (53.8) 47.0 (55.2) 58.8 (75.3)
Values presented as mean with SD in parentheses; B: Blood; C: cerebral microdialysate; L/P-ratio: lactate/pyruvate ratio. Control group: C-group; Intervention
group: P-group;
**:P < 0.01; within group difference compared with baseline values.
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plasma volume contraction and deterioration of global
perfusion. This constitutes a potential vicious circle in
the development of IAH and organ failure, and has, to
our knowledge, not previously been demonstrated in a
large animal model.
In the present study both CVPRA and CVPFV were
elevated in the P-group animals. Theoretically, capillary
hydrostatic pressure (Pc ) depends on venous pressure (Pv),
venous resistance (Rv) and blood flow (F) according to the
following equation: Pc = Pv + F ∙ Rv [16]. Hence, the differ-
ence in fluid extravasation could be related to an increase
of capillary hydrostatic pressure (Pc) in the P-group.Table 4 Total tissue water content (TTW)
Tissue C-group P-group P
Right myocardium 4.15 (0.32) 4.04 (0.14) NS
Left myocardium 3.98 (0.15) 3.87 (0.13) NS
Lung 5.21 (0.25) 4.86 (0.19) <0.01
Liver 3.47 (0.29) 3.66 (0.15) NS
Right kidney 5.42 (0.75) 4.70 (0.22) <0.05
Left kidney 5.36 (0.74) 4.55 (0.28) <0.05
Stomach (muscularis) 4.79 (0.31) 4.50 (0.36) NS
Stomach (mucosa) 4.77 (0.99) 4.08 (0.29) NS
Pancreas 3.00 (0.53) 3.15 (0.23) NS
Ileum (muscularis) 4.69 (0.59) 4.39 (0.34) NS
Ileum (mucosa) 5.33 (0.27) 4.82 (0.82) NS
Skeletal muscle 4.07 (0.40) 4.09 (0.32) NS
Skin 2.84 (0.46) 2.68 (0.65) NS
Brain 4.54 (0.27) 4.35 (0.32) NS
Results presented as mean with SD in parentheses. Control group: C-group;
Intervention group: P-group.Reduced lymphatic drainage from the abdominal cav-
ity to the systemic circulation has been reported in dogs
after elevation of intra-abdominal pressure to 20 mmHg
[17]. This could also be a factor contributing to plasma
volume contraction in IAH. Another potential mechan-
ism could be increased capillary permeability due to is-
chemia and subsequent local inflammation. The present
data does not support this hypothesis, however, since
the levels of pro-inflammatory cytokines were low and
did not differ between the groups.
In the current study, elevation of IAP caused a reduction
in global perfusion as well as in the microcirculation of in-
testinal and ventricular mucosa, pancreas and the kidneys.
This is in accordance with multiple animal studies and hu-
man case reports describing reduced intestinal perfusion
due to elevated IAP [18-20]. On the other hand, cerebral
perfusion increased slightly in the P-group, despite elevated
intracranial pressure and a trend to reduction in cerebral
perfusion pressure. The explanation could be an effect on
cerebrovascular resistance caused by the slightly lower pH
in the P-group. Previous experimental studies also reported
raised intracranial pressure during conditions of intra-
abdominal hypertension. A mechanism of compromised
cerebral venous drainage has been suggested [21,22]. Never
the less, the stable levels of cerebral glycerol and lactate/
pyruvate ratio in both study groups indicate adequate cere-
bral supply of oxygen and energy substrates during the
experiments.
A few limitations of the study should be mentioned.
The study is weakened by the postmortem data on water
content in various tissue and organs where most samples
showed no difference between the groups. The explan-
ation is not clear, but could be related to the methods
lack of sensitivity. Another explanation could be the fact
Table 5 Microcirculatory flow
Baseline 240 min
Tissue C-group P-group C-group P-group
Ileum muscularis 0.154 (0.192) 0.136 (0.152) 0.149 (0.210) 0.105 (0.122)
Ileum mucosa 0.373 (0.092) 0,462 (0.083) 0.372 (0.049) 0.364 (0.095)*
Corp.muscularis 0.053 (0,002) 0.055 (0.010) 0,065 (0,017)* 0,050 (0,015)
Corp.mucosa 0.350 (0,108) 0,352 (0.057) 0,396 (0,104) 0,291 (0,041)*
Pancreas 0.293 (0,048) 0.379 (0.11) 0.402 (0.060)* 0.255 (0.028)*###
Right kidney 2.385 (0.271) 3.136 (0.488)## 1.969 (0.384)* 1.506 (0.361)*
Left kidney 2.437 (0.187) 3.063 (0.484)## 2.006 (0.363)* 1.540 (0.397)*
Skin 0,014 (0,004) 0,016 (0,007) 0,018 (0,004)* 0,011 (0,003)#
Brain 0.366 (0.186) 0.386 (0.102) 0.354 (0.096) 0.489 (0.153)*
Right ventricle 0.511 (0.252) 0.654 (0.286) 0.583 (0.432) 0.633 (0.292)
Left ventricle 0.537 (0.274) 0.738 (0.331) 0.599 (0.441) 0.664 (0.342)
Muscle 0.021 (0.009) 0.022 (0.004) 0.021 (0.01) 0.018 (0.006)
Microcirculatory flow in ml/min/100 g tissue; Results as means with SD in parentheses; Control group: C-group; Intervention group: P-group;
*: P < 0.05; within group difference compared with baseline values;
#: P < 0.05 ##: P < 0.01 ###: P < 0.001; between group difference, same time.
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high compliance, as for instance subcutaneous or retro-
peritoneal loose connective tissue [23]. Unfortunately,
the range of samples did not include these. The present
data are not able to determine the edema distribution in
the experimental model and the issue should be ad-
dressed in a future study on IAH.
The data on kidney microcirculation surprisingly showed
higher flow in the P-group than the C-group prior to inter-
vention. Biologic variation and small numbers of animals in
the study groups presumably could contribute to this. How-
ever, the percentage change after intervention demon-
strated a significant difference between the groups, with a
marked reduction in kidney perfusion seen in the P-group.
This is consistent with data from other animal studies, sug-
gesting that the mechanism of renal failure in IAH could be
related to inadequate arterial blood flow and GFR [24,25].
It underscores the fact that IAH is an independent risk
factor for acute renal failure [4].
The experimental model does not quite mimic the clinical
situation of intraabdominal hypertension, since no under-
lying pathology is present. The study was designed to ex-
plore the pathophysiological effects of elevated IAP on fluid
shifts, independent of the underlying disorder. The findings
may be relevant for the understanding of secondary ACS
since intra-abdominal edema of various origins could be
aggravated by the mechanism of a vicious circle. The results
underline the importance of early interventions to prevent
or treat acutely elevated intra-abdominal pressure.
Most experimental models on IAH have introduced car-
bon dioxide or saline into the abdominal cavity to raise IAP
[26]. These models are limited by potential systemic effects
following absorption of saline or by acid-base disordersfollowing absorption of carbon dioxide [27]. In the present
model, we applied insufflation of the inert gas helium,
which has been associated with better cardiovascular stabil-
ity in laparoscopic surgery when compared with CO2 [28].
Various methods for monitoring IAP have been evalu-
ated in the literature and the measurement of urinary
bladder pressure is advocated as the golden standard in
the clinical routine [7]. In animal models CVPFV has
been shown to correlate well with changes in IAP. Our
data are in line with this, showing that IAP and CVPFV
in the C-group corresponds and remained stable during
the experiment, while in the P-group there was a signifi-
cant, and parallel increase in IAP and CVPFV. Clinical
studies, however, do not support the routine use of
CVPFV for monitoring IAP due to lack of accuracy in
the lower pressure range [10,29].
Conclusion
In this porcine model of acute elevated intraabdominal pres-
sure by insufflation of helium, the intervention was associ-
ated with increased extravasation of fluid and proteins,
plasma volume reduction, reduced cardiac output and re-
duced perfusion of intraabdominal organs. The findings sup-
port the clinical recommendation of preventing IAH before
hypo-perfusion and organ failure develops.
Key message
Elevated intra-abdominal pressure is an independent
cause of increased fluid extravasation rate and reduced
plasma volume.
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